M yocardial ischaemia is responsible for angina, unstable angina, and, less commonly, shortness of breath secondary to ischaemic left ventricular dysfunction (angina equivalent) as well as cardiac arrhythmias. This article will deal with the mechanisms of myocardial ischaemia likely to be encountered in patients presenting with the chronic coronary insufficiency and stable symptoms of angina. It will not deal with the vessel wall based mechanisms of unstable or acute coronary syndromes which are covered elsewhere in this series. BASIC PRINCIPLESc The undergraduate, see-saw diagram showing the perfect match between myocardial oxygen consumption (MV̇O2) and oxygen delivery to the myocardium remains at the core of our understanding of myocardi...
Atherosclerosis is a chronic disease which mainly represents an inflammatory response in the vessels...
We enjoyed reading the Letter to the Editor by Madias published in the Journal recently. Our study g...
We read with interest the clinician update by Buckley and Di Carli1 that reviews the indications, ac...
Ischaemic heart disease is a major health problem in the western world. In many cases the first symp...
Myocardial infarction (MI) is a major public health problem and the leading cause of human mortality...
D ow nloaded from DOI: 10.1161/CIRCULATIONAHA.112.150425 2 There are very few things in medicine whi...
To the Editor: I read with interest the excellent Contemporary Review in Cardio-vascular Medicine on...
he ischaemic cascade1 describes the temporal sequence of pathophysiological events initiated by an i...
c AMP cyclic adenosine monophosphate CAD coronary artery disease cGMP cyclic guanosine monophosphate...
Background: Few data are available on the behavior of myocardial ischemia during daily activities in...
IN 1959 Selyel reported that myocardial resistance to cardiotoxic agents was reduced by intracellu-l...
A cute myocardial infarction (AMI) is a particularly sig-nificant event in the natural course of the...
SUMMARY. Thrombolytic therapy has gained widespread ac-ceptance as a means of t reat ing coronary ar...
Tissue hypoxia is a key factor for cell death after acute myocardial infarction (MI). It seems that ...
textabstractThe function of the heart is to pump blood from the veins into the arteries in response ...
Atherosclerosis is a chronic disease which mainly represents an inflammatory response in the vessels...
We enjoyed reading the Letter to the Editor by Madias published in the Journal recently. Our study g...
We read with interest the clinician update by Buckley and Di Carli1 that reviews the indications, ac...
Ischaemic heart disease is a major health problem in the western world. In many cases the first symp...
Myocardial infarction (MI) is a major public health problem and the leading cause of human mortality...
D ow nloaded from DOI: 10.1161/CIRCULATIONAHA.112.150425 2 There are very few things in medicine whi...
To the Editor: I read with interest the excellent Contemporary Review in Cardio-vascular Medicine on...
he ischaemic cascade1 describes the temporal sequence of pathophysiological events initiated by an i...
c AMP cyclic adenosine monophosphate CAD coronary artery disease cGMP cyclic guanosine monophosphate...
Background: Few data are available on the behavior of myocardial ischemia during daily activities in...
IN 1959 Selyel reported that myocardial resistance to cardiotoxic agents was reduced by intracellu-l...
A cute myocardial infarction (AMI) is a particularly sig-nificant event in the natural course of the...
SUMMARY. Thrombolytic therapy has gained widespread ac-ceptance as a means of t reat ing coronary ar...
Tissue hypoxia is a key factor for cell death after acute myocardial infarction (MI). It seems that ...
textabstractThe function of the heart is to pump blood from the veins into the arteries in response ...
Atherosclerosis is a chronic disease which mainly represents an inflammatory response in the vessels...
We enjoyed reading the Letter to the Editor by Madias published in the Journal recently. Our study g...
We read with interest the clinician update by Buckley and Di Carli1 that reviews the indications, ac...